Merck logo

Senior Principal Scientist (Senior Scientific Director Level), Non Clinical Drug Safety

Merck

West Point, PA; Boston, MA; South San Francisco, CA; Cambridge, MAHybridPosted 3 days ago$194,100.00 - $305,600.00
Full TimeSenior LevelResearch & ScientistPharmaceutical
Original posting ↗

Summary

We are seeking a Discovery Program Leader to represent Nonclinical Drug Safety on discovery research teams and in scientific and strategic review meetings. This position requires exceptional leadership, collaboration, and independence, and a passion to work collaboratively across functions and sites to discover novel medicines that improve the lives of patients.

Job description

The Discovery Program Leader is responsible for defining and overseeing the Nonclinical Drug Safety strategy for programs in all modalities (including small molecules, peptides, biologics and ADC programs) from Target Identification through to the approval of First-In-Human enabling GLP toxicity studies. They are responsible for 1) providing risk assessments for targets, 2) de-risking strategies for discovery programs and 3) collaborating with Nonclinical Drug Safety staff at other sites to execute on the appropriate studies to support selection of therapeutic targets, and the identification and development of new drug candidates. The Discovery Program Leader may also serve on development teams with responsibility for defining the GLP toxicology study strategy and execution, and for the non-clinical safety sections of regulatory documents that support clinical trials and worldwide marketing authorization.

In this role you will:

  • Represent Nonclinical Drug Safety on discovery teams and participate in therapeutic area discovery governance committee reviews.
  • Promote and facilitate creative thinking from target identification/validation through lead optimization in Infectious Disease, Neuroscience, Immunology, Oncology, and/or Cardiometabolic Therapeutic Areas.
  • Be a "drug creator" and promoter of innovative thinking by influencing both cross-site disease area aligned groups, as well as functional area disciplines.
  • Identify and assess potential risks associated with therapeutic targets or development candidates using available literature, internal data, and external information.
  • The individual may also lead early development teams, informing on preclinical studies to support product development.

Qualifications, Skills and Experience Needed:

  • PhD in relevant field, DVM, MD degree or equivalent.
  • Minimum 10+ years of demonstrated pharmaceutical industry experience as a non-clinical safety scientist (e.g. Toxicology, Pathology etc.) and/or as non-clinical safety assessment representative to a cross-functional development and/or discovery team.
  • Experience with small molecule pharmaceutical discovery.
  • Demonstrated ability to successfully navigate cross-functional lines and drive team decision making in a matrix organizational structure.
  • Highly dedicated, motivated, resilient, and flexible; capable of creative problem solving and delivering on goals and objectives in a timely fashion.
  • Excellent team player who can work collaboratively with discovery team members from various functions, other Discovery Program Leader and scientists responsible for study conduct and portfolio management.
  • Excellent interpersonal skills, able to establish good working relationships within networks of employees of all levels.
  • Excellent communicator who knows when and how to speak up and appropriately raise issues to stakeholders and to management.

Preferred experience:

  • Experience with biopharmaceutical and/or small molecule pharmaceutical development.
  • Experience with regulatory submissions and responses.
  • Member of pharmaceutical consortia and/or external scientific or professional organizations.

Required Skills:

Clinical Safety, Drug Target Identification, Human Health Risk Assessment, Lead Optimization, Mentorship, Molecular Biology, Omics Technologies, Pre-Clinical Developments, Preclinical Research, Process Characterization, Project Leadership, Regulatory Submissions, Safety Risk Assessments, Small Molecule Drug Development, Toxicity Studies

Requirements

  • PhD in relevant field, DVM, MD degree or equivalent
  • Minimum 10+ years of demonstrated pharmaceutical industry experience as a non-clinical safety scientist (e.g. Toxicology, Pathology etc.) and/or as non-clinical safety assessment representative to a cross-functional development and/or discovery team
  • Experience with small molecule pharmaceutical discovery
  • Demonstrated ability to successfully navigate cross-functional lines and drive team decision making in a matrix organizational structure
  • Highly dedicated, motivated, resilient, and flexible; capable of creative problem solving and delivering on goals and objectives in a timely fashion
  • Excellent team player who can work collaboratively with discovery team members from various functions, other Discovery Program Leader and scientists responsible for study conduct and portfolio management
  • Excellent interpersonal skills, able to establish good working relationships within networks of employees of all levels
  • Excellent communicator who knows when and how to speak up and appropriately raise issues to stakeholders and to management
  • Clinical Safety
  • Drug Target Identification
  • Human Health Risk Assessment
  • Lead Optimization
  • Mentorship
  • Molecular Biology
  • Omics Technologies
  • Pre-Clinical Developments
  • Preclinical Research
  • Process Characterization
  • Project Leadership
  • Regulatory Submissions
  • Safety Risk Assessments
  • Small Molecule Drug Development
  • Toxicity Studies

Benefits

  • Medical, Dental & Vision
  • 401(k) Matching
  • Retirement Benefits
  • Paid Holidays
  • Vacation
  • Compassionate & Sick Days
  • Annual Bonus
  • Long-Term Incentive

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.